Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Nabi foresees phase I/II trials on CMV NeutraGAM

April 5, 1996

Lidakol formulations receive patent protection

April 5, 1996

BILD-1351 for HSV infection

April 5, 1996

BMS discloses novel cephalosporins

April 5, 1996

MBI-10 antibiotics effective against resistant staphylococci

April 5, 1996

Glaxo Wellcome, Quidel collaborate on flu management

March 15, 1996

Lidakol clinical trial update

March 15, 1996

Antiviral drugs from Glaxo Wellcome

March 15, 1996

Human lactoferrin produced in transgenic animals

March 15, 1996

UR-9751 dropped from development

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 1, 2025.
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Marks’ departure intensifies regulatory uncertainty at US FDA
BioWorld
Peter Marks’ March 28 letter giving one week’s notice of his resignation as director of the U.S. FDA’s Center for Biologics Evaluation and Research (CBER) is...